论文部分内容阅读
2015年1月7日,美国礼来动物保健公司(Elanco,礼来动保)宣布其已完成对诺华动物保健(Novartis Animal Health)的收购,成为全球动保行业新的领导者,并将为行业提供更多创新与价值。继2014年初收购罗曼动保后,礼来动保在2014年4月宣布收购诺华。这两项战略投资旨在为公司提供更多元化的产品组合,并更好地帮助客户持续发展其业务。新产品组合中除了客户熟知的礼来动保领导品牌外,还包括治疗、疫苗、驱虫剂、抗菌剂、外科产品、酶制剂、食品安全等领域近300个品牌。
On January 7, 2015, Eli Lilly and Company (Elaboration) announced that it has completed the acquisition of Novartis Animal Health and is a new leader in the global health and safety industry and will provide Industry to provide more innovation and value. Following the acquisition of Romance in early 2014, Lilly Mobility announced the acquisition of Novartis in April 2014. These two strategic investments are designed to provide companies with a more diversified product portfolio and to better help them keep growing their businesses. The new product portfolio includes nearly 300 brands in the areas of therapeutics, vaccines, insect repellents, antibacterials, surgical products, enzyme preparations and food safety, in addition to the well-known leadership of Eli Lilly and Company.